Company Product Description Indication Status
Akili Interactive Labs Inc., of Boston  Endeavorrx  Game-based digital therapeutic device  Prescription treatment for children with attention-deficit hyperactivity disorder FDA cleared the digital therapeutic
Arch Biopartners Inc., of Toronto Metablok LSALT peptide COVID-19 FDA cleared firm to proceed with phase II trial testing drug in preventing acute lung and kidney injury in patients with COVID-19
Edesa Biotech Inc., of Toronto EB-05  Monoclonal antibody targeting Toll-like receptor 4 Moderate to severe COVID-19 Health Canada approved the start of the phase II/III study
Eli Lilly and Co., of Indianapolis Lyumjev (insulin lispro-aabc) Rapid-acting insulin Type 1 and type 2 diabetes FDA approved the drug
Jazz Pharmaceuticals plc, of Dublin, and Pharmamar SA, of Madrid Zepzelca (lurbinectedin) Alkylating drug that binds guanine residues within DNA Metastatic small-cell lung cancer  FDA approved the drug for use in patients with disease progression on or after platinum-based chemotherapy
Valeo Pharma Inc., of Montreal Ethacrynate sodium Loop diuretic Congestive heart failure, acute pulmonary edema, renal edema, hepatic cirrhosis with ascites FDA approved the abbreviated NDA


For more information about individual companies and/or products, see Cortellis.

No Comments